PHARMACEUTICAL USES OF CYCLODEXTRINS AND DERIVATIVES

被引:131
作者
DUCHENE, D
WOUESSIDJEWE, D
机构
[1] Laboratoire de Pharmacie Galénique et Biopharmacie URA CNRS 1218, Université de Paris-Sud (Paris XI), Malabry
关键词
D O I
10.3109/03639049009058543
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Due to their particular conformation, cyclodextrins have the remarkable characteristic of being able to include various kinds of molecule inside their hydrophobic cavity, conferring on them an environmental hydrophily. These inclusion compounds have completely new pharmacotechnical properties, but the most important ones concern increases in water solubility and bioavailability. When administered orally, the inclusion compounds decompose, allowing the free active ingredient to be absorbed by the gastro-intestinal mucosa. However, a certain proportion of inclusion compound is absorbed without any dissociation. Some cyclodextrin derivatives are very interesting because of their very high water solubility, and also because of their low parenteral toxicity compared with the original βcyclodextrin. However, in parenteral administration, it is absolutely necessary to study the pharmacokinetic and pharmacological characteristics of the inclusion compound, which must be considered as the true active ingredient. © 1990 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:2487 / 2499
页数:13
相关论文
共 51 条
[41]   O-CARBOXYMETHYL-O-ETHYLCYCLOMALTOHEPTAOSE AS A DELAYED-RELEASE-TYPE DRUG CARRIER - IMPROVEMENT OF THE ORAL BIOAVAILABILITY OF DILTIAZEM IN THE DOG [J].
UEKAMA, K ;
HORIUCHI, Y ;
IRIE, T ;
HIRAYAMA, F .
CARBOHYDRATE RESEARCH, 1989, 192 :323-330
[42]   ETHYLATED BETA-CYCLODEXTRINS AS HYDROPHOBIC DRUG CARRIERS - SUSTAINED-RELEASE OF DILTIAZEM IN THE RAT [J].
UEKAMA, K ;
HIRASHIMA, N ;
HORIUCHI, Y ;
HIRAYAMA, F ;
IJITSU, T ;
UENO, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (08) :660-661
[43]   IMPROVEMENT OF THE ORAL BIOAVAILABILITY OF DIGITALIS GLYCOSIDES BY CYCLODEXTRIN COMPLEXATION [J].
UEKAMA, K ;
FUJINAGA, T ;
HIRAYAMA, F ;
OTAGIRI, M ;
YAMASAKI, M ;
SEO, H ;
HASHIMOTO, T ;
TSURUOKA, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (11) :1338-1341
[44]   STABILIZATION OF ISOSORBIDE 5-MONONITRATE IN SOLID-STATE BY BETA-CYCLODEXTRIN COMPLEXATION [J].
UEKAMA, K ;
OH, K ;
IRIE, T ;
OTAGIRI, M ;
NISHIMIYA, Y ;
NARA, T .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1985, 25 (03) :339-346
[45]  
UEKAMA K, 1985, PHARM INT, V6, P61
[46]  
Uekama K., 1987, CYCLODEXTRINS THEIR, P395
[47]   STABILIZATION OF TINCTURES WITH CYCLODEXTRINS - A TINCTURE FROM THE FRUITS OF OENANTHE-AQUATICA L [J].
VINCIERI, FF ;
MULINACCI, N ;
MAZZI, G ;
CORAN, SA ;
BAMBAGIOTTIALBERTI, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 48 (1-3) :119-124
[48]   SOME PHYSICOCHEMICAL PROPERTIES OF BRANCHED BETA-CYCLODEXTRINS AND THEIR INCLUSION CHARACTERISTICS [J].
YAMAMOTO, M ;
YOSHIDA, A ;
HIRAYAMA, F ;
UEKAMA, K .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 49 (02) :163-171
[49]   PHARMACEUTICAL EVALUATION OF HYDROXYALKYL ETHERS OF BETA-CYCLODEXTRINS [J].
YOSHIDA, A ;
ARIMA, H ;
UEKAMA, K ;
PITHA, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 46 (03) :217-222
[50]  
YOSHIDA A, 1989, CHEM PHARM BULL, V37, P1059